NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Allotex

Allotex

Private
Boston, MassachusettsHealthcare & Life Scienceshttps://allotex.com/

Last Round

Series B

Extension

Nov 30, 2023

Total Funding Raised

$46.7M

Company Overview

Allotex is a biotechnology and medical device company that develops tissue-based solutions for refractive vision correction using precisely-shaped human corneal allografts.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology, Clinical Trials

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

corneal inlayrefractive surgerypresbyopia correctionvision correctionophthalmic biologicshyperopia treatmentcorneal allografttissue additionminimally invasive surgeryeye surgeryvision implantsLASIK alternativemedical devicerefractive implant

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Allotex Comparables

Compare Allotex with similar companies based on industry and business-model similarity.

Allotex comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
TECLens, Inc.
80%
CorneaGen
78%
LinkoCare Life Sciences
74%

Allotex Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series B ExtensionNov 30, 2023
Series BJul 9, 2023
Series BFeb 1, 2018

Allotex Investors

Notable investors and investment history

Allotex investors
InvestorRounds
KCK MedTechSeries B Extension, Series B
Junson CapitalSeries B, Series B Extension
Supernova InvestSeries B Extension, Series B
Panakès PartnersSeries B
ExorSeries B
Exor VenturesSeries B Extension, Series B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 9, 2023

    $30M round led by KCK MedTech.

Allotex Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Allotex Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Allotex's valuation, stock price, and market status.

Firmographic Details

HeadquartersBoston, Massachusetts
Employee Range30
Year Founded2014
Last FundingNov 30, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.